Cardio Diagnostics Holdings, Inc.
CDIO
$2.88
-$0.06-2.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -55.74% | -50.13% | -39.51% | 105.29% | 181.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -55.74% | -50.13% | -39.51% | 105.29% | 181.10% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -55.74% | -50.13% | -39.51% | 105.29% | 181.10% |
| SG&A Expenses | -22.68% | -26.20% | -39.85% | 18.02% | 6.26% |
| Depreciation & Amortization | 428.13% | 252.08% | 164.06% | -47.40% | -47.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.24% | -26.13% | -39.79% | 15.72% | 4.15% |
| Operating Income | 22.10% | 26.01% | 39.79% | -15.51% | -3.87% |
| Income Before Tax | 20.61% | 28.76% | 49.12% | -0.08% | 11.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.61% | 28.76% | 49.12% | -0.08% | 11.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.61% | 28.76% | 49.12% | -0.08% | 11.88% |
| EBIT | 22.10% | 26.01% | 39.79% | -15.51% | -3.87% |
| EBITDA | 24.44% | 28.75% | 42.85% | -13.44% | -1.41% |
| EPS Basic | 64.80% | 67.15% | 77.52% | 52.35% | 57.81% |
| Normalized Basic EPS | 66.81% | 69.22% | 77.44% | 52.17% | 53.93% |
| EPS Diluted | 64.80% | 67.15% | 77.52% | 52.35% | 57.81% |
| Normalized Diluted EPS | 66.81% | 69.22% | 77.44% | 52.17% | 53.93% |
| Average Basic Shares Outstanding | 123.65% | 123.32% | 120.19% | 112.09% | 111.49% |
| Average Diluted Shares Outstanding | 123.65% | 123.32% | 120.19% | 112.09% | 111.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |